OTC - ACTIVE INGREDIENT SECTION
Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%
Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%
Anorectal/Hemorrhoidal
Helps relieve the pain, itching, and burning associated with hemorrhoids. Temporarily shrinks hemorrhoidal tissue. Temporarily provides a coating for relief of anorectal discomforts. Temporarily protects irritated areas and inflamed perineal skin.
For external use only.
When using this product do not exceed recommended dosage unless directed by a doctor, do not put this product into rectum by using fingers or any mechanical device or applicator.
Ask a doctor or pharmacist before use if you have difficulty in urination due to enlargement of the prostate gland, diabetes, heart disease, high blood pressure, thyroid disease, or you are presently taking a prescription for high blood pressure or depression.
Stop use and ask a doctor if condition worsens or does not improve within seven days, if bleeding occurs.
Ask a health care professional before use.
If swallowed, seek medical help or contact a Poison Control Center right away.
Adults: apply up to 3 times daily or after each bowl movement. When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or soft cloth before each application of this product. To use finger gots: roll one finger cot over finger. Gently squeeze cream onto finger cot. Smooth a layer of the cream over affected area.
Children under 12 years of age: consult your pediatrician.
Aloe barbadensis leaf extract, BHA, cellulose gum, cetyl alcohol, citric acid, disodium EDTA, ethylhexylglycerin, glyceryl stearate, mineral oil, panthenol, Phenoxyethanol, propyl gallate, propylene glycol, sorbitan olivate, steareth-21, stearyl alcohol, tocopherol, tocopheryl acetate, water, xanthan gum.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2642220 | glycerin 14.4 % / lidocaine 5 % / phenylephrine HCl 0.25 % / white petrolatum 15 % Rectal Cream | PSN | 1 |
| 2642220 | glycerin 144 MG/ML / lidocaine 50 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Cream | SCD | 1 |
| 2642220 | glycerin 14.4 % / lidocaine 5 % / phenylephrine HCl 0.25 % / white petrolatum 15 % Rectal Cream | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85996-173-00 | Norms Hemorrhoid | 2.8 g in 1 POUCH | CREAM | 2.8 | 1 | |
| 85996-173-00 | Norms Hemorrhoid | 5 in 1 CARTON | CREAM | 5 | 1 | |
| 85996-173-02 | Norms Hemorrhoid | 57 g in 1 TUBE | CREAM | 57 | 1 | |
| 85996-173-02 | Norms Hemorrhoid | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 85996-173-12 | Norms Hemorrhoid | 2.8 g in 1 POUCH | CREAM | 2.8 | 1 | |
| 85996-173-12 | Norms Hemorrhoid | 12 in 1 CARTON | CREAM | 12 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85996-173 | 85996-173-02, 85996-173-00, 85996-173-12 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norms Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Totally Normal Company | 3bdf8c74-3db6-1805-e063-6394a90aaba0 | 2025-08-08 | Warnings | 85996-173-12 85996-173-02 85996-173-00 85996-173 85996017300 85996017302 85996017312 3bdf8c74-3db7-1805-e063-6394a90aaba0 3bdf8c74-3db6-1805-e063-6394a90aaba0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.